Ancestry-based pharmacogenomics, adverse reactions and carbamazepine: is the FDA warning correct?

Authors

P. W. Payne, George Washington UniversityFollow

Document Type

Journal Article

Publication Date

10-1-2014

Journal

The pharmacogenomics journal

Volume

14

Issue

5

Inclusive Pages

473-80

DOI

10.1038/tpj.2014.14

Keywords

Anticonvulsants--adverse effects; Asian Continental Ancestry Group--genetics; Carbamazepine--adverse effects; HLA-B15 Antigen--genetics; United States Food and Drug Administration--legislation & jurisprudence

APA Citation

Payne, P. W. (2014). Ancestry-based pharmacogenomics, adverse reactions and carbamazepine: is the FDA warning correct? The Pharmacogenomics Journal, 14(5): 473–480. doi: 10.1038/tpj.2014.14.

Peer Reviewed

1